Fludarabine, Cyclophosphamide, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Hematologic Cancer

NCT00134004 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

210

Enrollment

OTHER

Sponsor class

Conditions

Chronic Myeloproliferative Disorders
Leukemia
Lymphoma
Multiple Myeloma and Plasma Cell Neoplasm
Myelodysplastic Syndromes

Interventions

DRUG: cyclophosphamide
DRUG: fludarabine phosphate
DRUG: mycophenolate mofetil
DRUG: tacrolimus
PROCEDURE: allogeneic bone marrow transplantation
RADIATION: radiation therapy

Sponsor

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Collaborators

[object Object]